Molecular Biology Program
Veronica Rodriguez-Bravo has not added Biography.
If you are Veronica Rodriguez-Bravo and would like to personalize this page please email our Author Liaison for assistance.
Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
Cancer research Sep, 2006 | Pubmed ID: 16951182
Different S/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition.
Cancer research Dec, 2007 | Pubmed ID: 18089794
The decision to enter mitosis: feedback and redundancy in the mitotic entry network.
The Journal of cell biology Apr, 2009 | Pubmed ID: 19364923
Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells.
PLoS biology May, 2009 | Pubmed ID: 19468302
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.
Cancer cell Sep, 2012 | Pubmed ID: 22975379
Nuclear pores protect genome integrity by assembling a premitotic and mad1-dependent anaphase inhibitor.
Cell Feb, 2014 | Pubmed ID: 24581499
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.
Cancer cell Feb, 2015 | Pubmed ID: 25670080
The role of GATA2 in lethal prostate cancer aggressiveness.
Nature reviews. Urology Jan, 2017 | Pubmed ID: 27872477
The PP2A(B56) phosphatase promotes the association of Cdc20 with APC/C in mitosis.
Journal of cell science May, 2017 | Pubmed ID: 28404789
Targeting sarcoma tumor-initiating cells through differentiation therapy.
Stem cell research May, 2017 | Pubmed ID: 28433655
Mps1 Regulates Kinetochore-Microtubule Attachment Stability via the Ska Complex to Ensure Error-Free Chromosome Segregation.
Developmental cell Apr, 2017 | Pubmed ID: 28441529
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.
Cell 08, 2018 | Pubmed ID: 30100187
Memorial Sloan-Kettering Cancer Center
Icahn School of Medicine at Mount Sinai
Samuel J. Vidal1,
S. Aidan Quinn1,
Janis de la Iglesia-Vicente1,
Dennis M. Bonal1,
Veronica Rodriguez-Bravo2,
Adolfo Firpo-Betancourt1,
Carlos Cordon-Cardo1,
Josep Domingo-Domenech1
1Department of Pathology, Icahn School of Medicine at Mount Sinai,
2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center
Estrelania S. Williams1,
Veronica Rodriguez-Bravo3,
Uma Chippada-Venkata2,
Janis De Ia Iglesia-Vicente1,
Yixuan Gong2,
Matthew Galsky2,
William Oh2,
1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai,
2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai,
3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center
Lisa Mohr1,
Marc Carceles-Cordon1,
Jungreem Woo1,
Josep Domingo-Domenech1,
Veronica Rodriguez-Bravo1,2
2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Dan Han1,
Veronica Rodriguez-Bravo1,
Sudeh Izadmehr1,
Carlos Cordon-Cardo1
1Department of Pathology, Icahn School of Medicine at Mount Sinai
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
Исследования
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
Образование
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены
